2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Alpelisib and Fulvestrant to Treat Endometrial CancerDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceActive, not recruitingPhase 22026-07-30NCT05154487
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast CancerBreast Cancer - Infiltrating Ductal Carcinoma; HER-2 Positive Breast CancerRecruitingPhase 22026-05-01NCT07506876